Galenica AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Galenica AG with three other
drug stores in Europe:
Selcuk Ecza Deposu Ticaret ve Sanayi AS
sales of 7.48 billion Turkish Liras [US$2.01 billion]
of which 100%
was Medical and Hospital Equipment),
Oriola KD Oyj
(1.63 billion Euro [US$1.73 billion]
of which 73%
was Pharmaceutical Trade Sweden), and
based in Poland
(8.46 billion Polish New Zlotys [US$2.05 billion]
of which 69%
was Wholesale Trade).
Galenica AG reported sales of 3.79 billion Swiss Francs (US$3.76 billion)
December of 2015.
increase of 11.0%
versus 2014, when the company's sales were 3.42 billion Swiss Francs.
Sales at Galenica AG have increased during each of the previous five years
(and since 2010, sales have increased a total of 22%).
Sales of Vifor Pharma saw an increase
that was more than double the company's growth rate: sales were up
36.9% in 2015, from
706.20 million Swiss Francs to 967.02 million Swiss Francs.